NCT06262386View on ClinicalTrials.gov

Combined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility Trial

NARecruitingINTERVENTIONAL
Enrollment

358

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2028

Conditions
Lung CancerRelapse/Recurrence
Interventions
DRUG

Cisplatin based chemottherapy

adjuvant therapy for high risk patient

Trial Locations (1)

333

RECRUITING

Ching-Yang Wu, Taoyuan

All Listed Sponsors
collaborator

National Science and Technology Council

FED

lead

Chang Gung Memorial Hospital

OTHER